Gene · 10
Papers3,552
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
41 to 60 of 3,552
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Pharmacogenomics and mutation informatics: correlation of NAT2 mutations and isoniazid acetylation rate. | Drug Discov Today | 2026 | 41314532 | PubTator, text mining | PubMed |
| NAT2 Polymorphisms and Antituberculosis-Induced Hepatotoxicity in Thai People Living With HIV: Insights From a Pharmacogenetic-Pharmacokinetic Cohort Study. | J Infect Dis | 2026 | 41037485 | PubTator, text mining | PubMed |
| Pharmacogenetics of First-Line Antitubercular Drugs: An Update. | Ther Drug Monit | 2026 | 40903183 | PubTator, text mining | PubMed |
| Report on the 2024 international phase II/N-acetyltransferase workshop. | Arch Toxicol | 2026 | 40885834 | PubTator, text mining | PubMed |
| Hepatotoxicity Among People With HIV and Receiving Isoniazid Preventive Therapy in Pregnancy and Postpartum: The Role of Antiretroviral Regimen and Pharmacogenetics. | Clin Infect Dis | 2026 | 40237651 | PubTator, text mining | PubMed |
| The role of NAT2 genetic variants in anti-tuberculosis drug-induced liver injury (AT-DILI): a meta-analysis. | Pharmacogenomics | 2025 | 41657030 | PubTator, text mining | PubMed |
| Importance of genetic ancestry in pharmacogenomics for precision medicine. | Pharmacogenomics | 2025 | 41652975 | PubTator, text mining | PubMed |
| Association of GSTM1, NAT2 Gene Polymorphisms and Susceptibility to Renal cell carcinoma in Mongolia: A Case-Control Study. | Asian Pac J Cancer Prev | 2025 | 41459865 | PubTator, text mining | PubMed |
| N-acetyltransferase (NAT) 1 and NAT2 enzyme activities drive interindividual variability in sulfamethoxazole N-acetylation. | Drug Metab Dispos | 2025 | 41344065 | PubTator, text mining | PubMed |
| Unraveling the Role of CYP2E1 in Antitubercular Drug-Induced Hepatotoxicity: From Molecular Mechanisms to Clinical Implications. | Int J Hepatol | 2025 | 41323558 | PubTator, text mining | PubMed |
| Characterisation of pharmacogenomic variation in the Shetland and Orkney Isles in Scotland. | Sci Rep | 2025 | 41298791 | PubTator, text mining | PubMed |
| Endophenotype Guided Genome-Wide Association Study to Enhance Genetic Risk Prediction of Primary Open-Angle Glaucoma in African Ancestry Populations. | medRxiv | 2025 | 41282865 | PubTator, text mining | PubMed |
| Pharmacogenetics in Tuberculosis-HIV Coinfected Populations: A Systematic Review of Genetic Variants Influencing Antiretroviral and Anti-Tuberculosis Drug Response. | J Multidiscip Healthc | 2025 | 41216483 | PubTator, text mining | PubMed |
| The Clinical Pharmacogenetics Implementation Consortium's consensus-based framework for assigning allele function. | Am J Hum Genet | 2025 | 41175864 | PubTator, text mining | PubMed |
| Genetic Landscape of VIP Pharmacogenomic Variants in the Kinh Vietnamese Population. | Pharmgenomics Pers Med | 2025 | 41112219 | PubTator, text mining | PubMed |
Influence of Glutathione S-transferase Mu 1 (GSTM1), Glutathione S-transferase Theta 1 (GSTT1), and N-acetyltransferase 2 (NAT2) Variants on Bladder Cancer Progression and Recurrence Rating: A Bosnian and Herzegovinian Case-Control Study. | Cureus | 2025 | 41084651 | PubTator, text mining | PubMed |
| NAT2 rapid acetylator phenotype and increased risk of tuberculosis retreatment: A TB cohort study in Northern Thailand. | Int J Infect Dis | 2025 | 41077328 | PubTator, text mining | PubMed |
| Pharmacogenetics of metamizole-induced agranulocytosis: a systematic review and drug regulation implications. | Front Pharmacol | 2025 | 41069600 | PubTator, text mining | PubMed |
| Characterization of the complex TB pharmacogenomic landscape in Africa using bioinformatic tools. | Brief Bioinform | 2025 | 40975835 | PubTator, text mining | PubMed |
| Clinical Pharmacogenetics Implementation Consortium Guideline for NAT2 Genotype and Hydralazine Therapy. | Clin Pharmacol Ther | 2025 | 40974042 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/10/papers?page=3